2015-09-18T07:30:23-05:00 2015-06-30 410746749 CLIFTONLARSONALLEN LLP 1301 W 22ND ST STE 1100 OAK BROOK IL 60523 990 2014-07-01 731386920 GATEWAY FOR CANCER RESEARCH GATE 8473427450 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 TERESA HALL BARTELS PRESIDENT 5473427450 2015-09-11 1 GREGORY S ADAMS P00095597 6305738600 2014 2016-02-25 16:41:14Z TERESA HALL BARTELS 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 3606435 0 X GATEWAYCR.ORG X 1991 OK TO FIND AND FUND CLINICAL CANCER RESEARCH. 20 20 0 0 0 0 3243122 3036651 0 0 226903 352043 0 0 3470025 3388694 2054135 3907418 0 0 0 0 0 0 0 56613 93468 2110748 4000886 1359277 -612192 11503362 12863957 3362295 5572657 8141067 7291300 X TO FUND MEANINGFUL AND BREAKTHROUGH CLINICAL TRIALS WORLDWIDE THAT HELP PEOPLE LIVING WITH CANCER TO FEEL BETTER, LIVE LONGER AND CONQUER CANCER TODAY! 0 0 3977283 3907418 GATEWAY FOR CANCER RESEARCH (FORMERLY KNOWN AS CANCER TREATMENT RESEARCH FOUNDATION OR CTRF), A NON-PROFIT 501(C)(3) ORGANIZATION, WAS ESTABLISHED IN 1991 TO PROMOTE RESEARCH THROUGH THE TREATMENT PROCESS AND SUPPORT PROGRESSIVE MOLECULAR, NUTRITIONAL AND IMMUNOLOGICAL RESEARCH PROGRAMS THAT MORE TRADITIONAL CANCER RESEARCH INSTITUTIONS MAY NOT FUND. GATEWAY IS DEDICATED TO ADVANCING INNOVATIONS IN THE SCIENTIFIC COMMUNITY AND SPEEDING THEM TO THE CANCER PATIENT'S BEDSIDE. THE WORK OF GATEWAY IS ABOUT GIVING CANCER PATIENTS THE ABILITY TO LIVE LONGER, MORE FULFILLING AND HEALTHIER LIVES.NO PORTION OF ANY PUBLIC CONTRIBUTION TO GATEWAY GOES TO FUNDRAISING OR ADMINISTRATIVE SALARIES. DUE TO GENEROUS CORPORATE UNDERWRITING OF ADMINISTRATIVE EXPENSES, 99% OF PUBLIC CONTRIBUTIONS RECEIVED ARE APPLIED DIRECTLY TO SUPPORT AGGRESSIVE CANCER RESEARCH AND SCIENTIFIC DEVELOPMENT PROGRAMS. OUR BOARD OF SCIENTIFIC COUNSELORS APPLIES STRINGENT GUIDELINES FOR REVIEWING EACH GRANT APPLICATION, RECOMMENDING TO THE BOARD OF DIRECTORS ONLY THOSE THAT ARE IN KEEPING WITH THE FOUNDATION'S MISSION. THROUGH THIS FORMAL REVIEW PROCESS, GATEWAY ENSURES THAT FUNDING IS GRANTED STRICTLY TO THOSE PROJECTS THAT ARE TRULY INNOVATIVE AND HAVE THE POTENTIAL TO QUICKLY TRANSLATE FROM THE RESEARCHER'S LABORATORY TO THE PATIENT'S BEDSIDE.AS THE NATION'S SECOND MOST DEADLY AND COSTLY DISEASE, CANCER RECOGNIZES NO BOUNDARIES. IN THE BATTLE AGAINST CANCER, GATEWAY IS ON THE FRONTLINES, SUPPORTING CLINICAL RESEARCH INITIATIVES DESIGNED TO ENHANCE QUALITY OF LIFE FOR CANCER PATIENTS, SURVIVORS, AND FAMILIES IN EVERY COMMUNITY NATIONWIDE. GATEWAY FOR CANCER RESEARCH HAS FUNDED OVER 120 STUDIES AND IS CURRENTLY FUNDING 36 STUDIES DEALING WITH NEW AGENT STUDIES, IMMUNOLOGY, NUTRITION, AND GENE THERAPY. COMPARED TO OTHER ORGANIZATIONS OF OUR SIZE, WE ARE CLEARLY AMONG THE MOST SUCCESSFUL OF CANCER RESEARCH FOUNDATIONS. THE QUALITY OF OUR FUNDED RESEARCH CONTINUES TO IMPROVE EVERY YEAR AS WE RELENTLESSLY PURSUE THE MOST EXCITING PROSPECTS FOR CUTTING EDGE CLINICAL RESEARCH WITH IMPORTANT PATIENT IMPACT.BECAUSE WE ARE VIGILANT ABOUT MONITORING OUR CLINICAL RESEARCH STUDIES, WE CAN ASSURE OUR FUNDING PARTNERS THE BEST UTILIZATION OF THEIR CONTRIBUTIONS. WE IDENTIFY AND ENCOURAGE GREATER INTERACTION WITH OUR RESEARCHERS AND ENCOURAGE APPLICATIONS FROM CLINICAL INVESTIGATORS WHO CONSISTENTLY PROVIDE US WITH IMPORTANT PATIENT IMPACT RESEARCH.HISTORICAL DOCUMENTATION OF OUR RESEARCH PROJECTS PROVIDES A WINDOW THROUGH WHICH WE CAN VIEW OUR PAST ACCOMPLISHMENTS AND IMPLEMENT NEW STRATEGIC PROGRAMS THAT REFLECT OUR MISSION - TO FUND MEANINGFUL AND BREAKTHROUGH CLINICAL TRIALS WORLDWIDE THAT HELP PEOPLE LIVING WITH CANCER TO FEEL BETTER, LIVE LONGER AND CONQUER CANCER TODAY! 3977283 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 39 0 0 0 0 0 0 0 1 1 0 0 0 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AZ CA CO CT FL IL ME MD MA MI MN MT MO NH NJ NY NC OH OK PA RI SC TN TX VA WA WI X X DIANE KINSLER 8473427450 1336 BASSWOOD ROAD SCHAUMBURG IL 60173 X JANICE ANDERSON DIRECTOR 0.30 X 0 0 0 DOTTIE RZESZUTKO DIRECTOR 0.30 X 0 0 0 BRUCE LUBIN DIRECTOR 0.30 X 0 0 0 ROBERT MAYO DIRECTOR 0.30 X 0 0 0 TERESA HALL BARTELS EX-OFFICIO, PRESIDENT 40.00 X X 0 0 0 DENIZ RAZON DIRECTOR 0.30 X 0 0 0 MICHAEL T MULLINS TREASURER 0.30 X X 0 0 0 RICHARD J STEPHENSON CHAIRMAN 0.30 X X 0 0 0 HARLAN TELLER VICE CHAIRMAN 0.30 X X 0 0 0 RHONDA KOKOT SECRETARY 0.30 X X 0 0 0 MARY LOU SMITH DIRECTOR 0.30 X 0 0 0 J TERRY SIMMONS DIRECTOR 0.30 X 0 0 0 SUSAN FLEMING DIRECTOR 0.30 X 0 0 0 HEATHER KANE DIRECTOR 0.30 X 0 0 0 EDWIN ROBERSON DIRECTOR 0.30 X 0 0 0 CHRISTOPHER SURDENIK DIRECTOR 0.30 X 0 0 0 MARIE NEWMAN DIRECTOR 0.30 X 0 0 0 EVA KMIECIC DIRECTOR 0.30 X 0 0 0 JENNIFER STEPHENSON KELLER DIRECTOR 0.30 X 0 0 0 TONY FESTA DIRECTOR 0.30 X 0 0 0 DAN GARMS DIRECTOR 0.30 X 0 0 0 STACIE J STEPHENSON DIRECTOR 0.30 X 0 0 0 0 0 0 0 0 0 0 SHERATON CHICAGO HOTEL & TOWERS 301 EAST NORTH WATER STREET CHICAGO IL 60611 GALA EVENT FACILITY SERVICES 215813 1 148544 2208157 679950 3036651 351188 351188 2766 1911 855 855 855 215830 2208157 215830 0 3388694 0 0 352043 3557792 3557792 349626 349626 20032 20032 BOARD OF SCIENTIFIC COU 49833 49833 BANK AND CREDIT CARD FE 23603 23603 4000886 3977283 23603 0 585061 447205 223836 2011410 257514 130461 5000 37000 10423025 10100452 8926 137429 11503362 12863957 3362295 5566657 6000 3362295 5572657 X 7970916 7133013 170151 158287 8141067 7291300 11503362 12863957 X -612192 -370662 133087 X X 0 1 X 1 0 X 1891889 2476644 3033342 3243122 3036651 13681648 1891889 2476644 3033342 3243122 3036651 13681648 681502 13000146 19924 21923 18209 226903 352043 639002 14320650 11351442 0.90780 0.91780 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 5616161 -370662 2269244 133087 215830 2247499 3368662 20032 20032 3388694 6465928 2269244 215830 2485074 3980854 20032 20032 4000886 PART X, LINE 2: THE FOUNDATION EVALUATES ITS EXPOSURE FOR UNCERTAIN TAX POSITIONS ON AN ANNUAL BASIS. AS OF JUNE 30, 2015 AND 2014, THERE WERE NO LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 215,830. PART XI, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES 20,032. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES NETTED WITH FUNDS GENERATED 215,830. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENTFEES 20,032. SCHEDULE D, PARTS XII AND XIII, LINES 2D AMOUNTS REPRESENT DIRECT EXPENSES FOR SPECIAL EVENTS HELD AND ARE REFLECTED IN PART VIII ON LINE 8B AGAINST REVENUES FROM FUNDRAISING EVENTS. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANTS FOR CANCER RESEARCH 113360 NORTH AMERICA - CANADA AND MEXICO, BUT BUT NOT THE UNITED STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANTS FOR CANCER RESEARCH 236266 0 0 0 0 0 0 349626 0 349626 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM CANCER RESEARCH 113360 CASH NORTH AMERICA - CANADA AND MEXICO, BUT BUT NOT THE UNITED STATES CANCER RESEARCH 236266 CASH 2 0 0 0 0 0 0 PART I, LINE 2: PROCEDURES ARE THE SAME AS DOMESTIC GRANTS. SEE SCHEDULE I. GALA FUNDRAISER 2145073 1929243 215830 215830 CURES AHEAD GOLF OUTING 220746 220746 1 58168 58168 2423987 2208157 215830 215830 215830 0 1 INSTITUTION BECKMAN RESEARCH INSTITUTE AT CITY OF HOPE 1500 DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 303650 CANCER RESEARCH CHILDREN'S HOSPITAL LOS ANGELES 4650 WEST SUNSET BOULEVARD LOS ANGELES CA 90027 951690977 501(C)(3) 86271 CANCER RESEARCH WASHINGTON UNIVERSITY SCHOOL OF MEDICINE 660 SOUTH EUCLID AVENUE PO BOX 8056 8056 ST LOUIS MO 63110 431519670 501(C)(3) 247323 CANCER RESEARCH UNIVERSITY OF IOWA COLLEGE OF MEDICINE 200 HAWKINS DRIVE 1528 JCP IOWA CITY IA 52242 237436761 501(C)(3) 63723 CANCER RESEARCH UNIVERSITY OF WASHINGTON SEATTLE CHILDREN'S HOSPITAL 4800 STAND POINT WAY NE SEATTLE WA 98105 910564748 501(C)(3) 345000 CANCER RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02115 042263040 501(C)(3) 653824 CANCER RESEARCH JOHN THEURER CANCER CENTER AT HACKENSACK UNIVERSITY 40 PROSPECT AVENUE HACKENSACK NJ 07601 221487576 501(C)(3) 288793 CANCER RESEARCH NORTHWESTERN UNIVERSITY 676 N CLAIR STREET SUITE 850 CHICAGO IL 60611 362167817 501(C)(3) 231220 CANCER RESEARCH UNIVERSITY OF MICHIGAN 1500 E MEDICAL CENTER DRIVE ANN ARBOR MI 48109 386006309 501(C)(3) 349197 CANCER RESEARCH DUKE UNIVERSITY MEDICAL CENTER DUMC 3085 05151A MORRIS BUILDING DURHAM NC 27710 560532129 501(C)(3) 232373 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 1429 FIRST AVENUE NEW YORK NY 10021 912154267 501(C)(3) 140545 CANCER RESEARCH STANFORD CANCER INSTITUTE 269 CAMPUS DRIVE STANFORD CA 94305 770312107 501(C)(3) 250000 CANCER RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE E G4818 SEATTLE WA 98010 916001537 501(C)(3) 269528 CANCER RESEARCH CITY OF HOPE 1500 DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 66345 CANCER RESEARCH THE FOUNDATION FOR BARNES-JEWISH HOSPITAL 1001 HIGHLANDS PLAZA DRIVE WEST SUITE 140 ST LOUIS MO 63110 237309937 501(C)(3) 30000 CANCER RESEARCH 14 0 PART I, LINE 2: ALL GRANT APPLICATIONS MUST GO THROUGH A RIGOROUS PEER REVIEW PROCESS LED BY OUR BOARD OF SCIENTIFIC COUNSELORS - A DISTINGUISHED BOARD OF RENOWNED SCIENTISTS, PHYSICIANS, RESEARCHERS AND PATIENTS. THROUGH THIS PROCESS, SCIENTISTS INCLUDING EXPERTS IN A PARTICULAR AREA OF CANCER REVIEW AND EVALUATE APPLICATIONS AGAINST A CAREFULLY PRESCRIBED SET OF CRITERIA FOR JUDGING THE SCIENTIFIC MERIT AND POTENTIAL VALUE OF EACH PROPOSED STUDY. THIS REVIEW, NOT ONLY INCLUDES A NUMERICAL GRADING OF OBJECTIVE CRITERIA, IT ALSO INCLUDES A SUBJECTIVE COMMENTARY WITH SUGGESTED MODIFICATIONS. UPON RECOMMENDATION BY THE BOARD OF SCIENTIFIC COUNSELORS, THE APPLICATION IS SUBMITTED TO GATEWAY'S BOARD OF DIRECTORS FOR FUNDING CONSIDERATION. THE STRINGENT REVIEW PROCESS, DESCRIBED ABOVE, IS CONTINUED DURING THE COURSE OF THE STUDY, IF APPROVED AND FUNDED, WHEN REQUIRED PROGRESS REPORTS ARE SUBMITTED. THE PROGRESS REPORTS ARE REVIEWED BY THE BOARD OF SCIENTIFIC COUNSELORS AND RECOMMENDATIONS AND MODIFICATIONS ARE MADE, IF DEEMED NECESSARY, BY THE BOARD PRIOR TO PAYMENT OF ADDITIONAL FUNDS. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS FIRST REVIEWED BY THE ORGANIZATION'S INTERNAL STAFF AND A SUBSEQUENT REVIEW BY EXECUTIVE STAFF. THE FORM 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AND SENT TO EACH CURRENT MEMBER OF THE BOARD FOR THEIR REVIEW AND ACTION. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S BOARD MEMBERS AND STAFF ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY DURING A REGULARLY SCHEDULED BOARD MEETING AND DURING THE STAFF MEMBERS ANNUAL PERFORMANCE EVALUATION MEETING. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC VIA IT'S WEBSITE AND OTHER NONPROFIT PUBLICATIONS. FORM 990, PART XI, LINE 9: RETURN OF UNUSED GRANT FUNDS 133,087. FORM 990, PART XII, LINE 2C THE ORGANIZATION'S BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.